Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo
- 8 January 2006
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 231 (1), 113-122
- https://doi.org/10.1016/j.canlet.2005.01.031
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Estradiol increases extracellular levels of vascular endothelial growth factorin vivo in murine mammary cancerInternational Journal of Cancer, 2003
- Estrogen Receptor-dependent and Estrogen Receptor-independent Pathways for Tamoxifen and 4-Hydroxytamoxifen-induced Programmed Cell DeathOnline Journal of Public Health Informatics, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Estrogen receptor beta in breast cancer.Endocrine-Related Cancer, 2002
- Is Resveratrol an Estrogen Agonist in Growing Rats?Endocrinology, 1999
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from GrapesScience, 1997
- Visualization of iron in cultured macrophages: A cytochemical light and electron microscopic study using autometallographyFree Radical Biology & Medicine, 1993
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysisCytometry, 1990